Cardibeltin

Cardibeltin Brand names, Cardibeltin Analogs

Cardibeltin Brand Names Mixture

Tarka (trandolapril + verapamil hydrochloride)

Cardibeltin Chemical_Formula

C₂₇H₃₈N₂O₄

Cardibeltin RX_link

http://www.rxlist.com/cgi/generic/verapsr.htm

Cardibeltin fda sheet

Cardibeltin FDA

Cardibeltin msds (material safety sheet)

Cardibeltin Synthesis Reference

Dengel, U.S. Pat. 3,261,859 (1966)

Cardibeltin Molecular Weight

454.602 g/mol

Cardibeltin Melting Point

< 25 ^oC

Cardibeltin H₂O Solubility

4.47 mg/L

Cardibeltin State

Liquid

Cardibeltin LogP

5.931

Cardibeltin Dosage Forms

Capsule (sustained-release); Liquid; Solution; Tablet; Tablet (extended-release)

Cardibeltin Indication

For the treatment of hypertension and angina.

Cardibeltin Pharmacology

Verapamil, a class IV antiarrhythmic agent, is used as a calcium-channel blocking (CCB) agent for the treatment of angina, hypertension, and for supraventricular tachyarrhythmias.

Cardibeltin Absorption

90%

Cardibeltin side effects and Toxicity

LD₅₀=8 mg/kg (i.v. in mice)

Cardibeltin Patient Information

Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses may need some adjustment, make sure to have your condition monitored regularly.

Cardibeltin Organisms Affected

Humans and other mammals